iriduim Ir 192
Term · Oncology and biomedicine · MLC-T-ONC-014573
A radioactive isotope of iridium. Iridium-192 emits gamma rays and has a half-life of 74 days. A high dose rate of this radioisotope can be used in brachytherapy to treat tumors by selectively delivering a cytotoxic dose of radiation to the tumor site.
| Identifier | MLC-T-ONC-014573 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | Ir-192 |
| Synonyms | iridium-192 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014573",
"term": "iriduim Ir 192",
"field": "Oncology and biomedicine",
"definition": "A radioactive isotope of iridium. Iridium-192 emits gamma rays and has a half-life of 74 days. A high dose rate of this radioisotope can be used in brachytherapy to treat tumors by selectively delivering a cytotoxic dose of radiation to the tumor site.",
"abbreviation": "Ir-192",
"synonyms": [
"iridium-192"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/iriduim-ir-192/"
}
Record 9,573 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.